nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftibuten—SLC15A2—Chlorpropamide—type 2 diabetes mellitus	0.111	0.136	CbGbCtD
Ceftibuten—SLC15A2—Tolbutamide—type 2 diabetes mellitus	0.099	0.121	CbGbCtD
Ceftibuten—SLC15A1—Chlorpropamide—type 2 diabetes mellitus	0.0957	0.117	CbGbCtD
Ceftibuten—SLC15A2—Ramipril—type 2 diabetes mellitus	0.0882	0.108	CbGbCtD
Ceftibuten—SLC15A1—Tolbutamide—type 2 diabetes mellitus	0.0853	0.104	CbGbCtD
Ceftibuten—SLC15A2—Nateglinide—type 2 diabetes mellitus	0.0842	0.103	CbGbCtD
Ceftibuten—SLC15A1—Ramipril—type 2 diabetes mellitus	0.076	0.0929	CbGbCtD
Ceftibuten—SLC15A1—Nateglinide—type 2 diabetes mellitus	0.0725	0.0887	CbGbCtD
Ceftibuten—SLC15A2—Glyburide—type 2 diabetes mellitus	0.0569	0.0695	CbGbCtD
Ceftibuten—SLC15A1—Glyburide—type 2 diabetes mellitus	0.049	0.0599	CbGbCtD
Ceftibuten—Asthenia—Glipizide—type 2 diabetes mellitus	0.000255	0.0014	CcSEcCtD
Ceftibuten—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000254	0.00139	CcSEcCtD
Ceftibuten—Pruritus—Glipizide—type 2 diabetes mellitus	0.000251	0.00138	CcSEcCtD
Ceftibuten—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000251	0.00138	CcSEcCtD
Ceftibuten—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.00025	0.00137	CcSEcCtD
Ceftibuten—Flatulence—Metformin—type 2 diabetes mellitus	0.000248	0.00136	CcSEcCtD
Ceftibuten—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000246	0.00135	CcSEcCtD
Ceftibuten—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000245	0.00135	CcSEcCtD
Ceftibuten—Chills—Irbesartan—type 2 diabetes mellitus	0.000245	0.00134	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000244	0.00134	CcSEcCtD
Ceftibuten—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000244	0.00134	CcSEcCtD
Ceftibuten—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000244	0.00134	CcSEcCtD
Ceftibuten—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000244	0.00134	CcSEcCtD
Ceftibuten—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000243	0.00134	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000243	0.00133	CcSEcCtD
Ceftibuten—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000243	0.00133	CcSEcCtD
Ceftibuten—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000243	0.00133	CcSEcCtD
Ceftibuten—Renal failure—Ramipril—type 2 diabetes mellitus	0.000241	0.00132	CcSEcCtD
Ceftibuten—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000241	0.00132	CcSEcCtD
Ceftibuten—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000241	0.00132	CcSEcCtD
Ceftibuten—Jaundice—Ramipril—type 2 diabetes mellitus	0.000239	0.00131	CcSEcCtD
Ceftibuten—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000238	0.0013	CcSEcCtD
Ceftibuten—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000238	0.0013	CcSEcCtD
Ceftibuten—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000237	0.0013	CcSEcCtD
Ceftibuten—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000237	0.0013	CcSEcCtD
Ceftibuten—Convulsion—Orlistat—type 2 diabetes mellitus	0.000236	0.0013	CcSEcCtD
Ceftibuten—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000236	0.0013	CcSEcCtD
Ceftibuten—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000236	0.0013	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000236	0.00129	CcSEcCtD
Ceftibuten—Dizziness—Glipizide—type 2 diabetes mellitus	0.000235	0.00129	CcSEcCtD
Ceftibuten—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000234	0.00129	CcSEcCtD
Ceftibuten—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000234	0.00128	CcSEcCtD
Ceftibuten—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000233	0.00128	CcSEcCtD
Ceftibuten—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000232	0.00128	CcSEcCtD
Ceftibuten—Dry mouth—Valsartan—type 2 diabetes mellitus	0.00023	0.00126	CcSEcCtD
Ceftibuten—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000229	0.00126	CcSEcCtD
Ceftibuten—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000227	0.00125	CcSEcCtD
Ceftibuten—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000227	0.00124	CcSEcCtD
Ceftibuten—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000226	0.00124	CcSEcCtD
Ceftibuten—Vomiting—Glipizide—type 2 diabetes mellitus	0.000226	0.00124	CcSEcCtD
Ceftibuten—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000225	0.00124	CcSEcCtD
Ceftibuten—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000225	0.00123	CcSEcCtD
Ceftibuten—Rash—Glipizide—type 2 diabetes mellitus	0.000224	0.00123	CcSEcCtD
Ceftibuten—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000224	0.00123	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000223	0.00123	CcSEcCtD
Ceftibuten—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000223	0.00122	CcSEcCtD
Ceftibuten—Headache—Glipizide—type 2 diabetes mellitus	0.000222	0.00122	CcSEcCtD
Ceftibuten—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000222	0.00122	CcSEcCtD
Ceftibuten—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00022	0.00121	CcSEcCtD
Ceftibuten—Flatulence—Losartan—type 2 diabetes mellitus	0.00022	0.00121	CcSEcCtD
Ceftibuten—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000219	0.0012	CcSEcCtD
Ceftibuten—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000219	0.0012	CcSEcCtD
Ceftibuten—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000219	0.0012	CcSEcCtD
Ceftibuten—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000218	0.0012	CcSEcCtD
Ceftibuten—Agitation—Irbesartan—type 2 diabetes mellitus	0.000218	0.0012	CcSEcCtD
Ceftibuten—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000218	0.0012	CcSEcCtD
Ceftibuten—Urticaria—Glyburide—type 2 diabetes mellitus	0.000217	0.00119	CcSEcCtD
Ceftibuten—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000216	0.00119	CcSEcCtD
Ceftibuten—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000216	0.00119	CcSEcCtD
Ceftibuten—Anorexia—Valsartan—type 2 diabetes mellitus	0.000215	0.00118	CcSEcCtD
Ceftibuten—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000214	0.00118	CcSEcCtD
Ceftibuten—Headache—Pioglitazone—type 2 diabetes mellitus	0.000213	0.00117	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000212	0.00116	CcSEcCtD
Ceftibuten—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000212	0.00116	CcSEcCtD
Ceftibuten—Nausea—Glipizide—type 2 diabetes mellitus	0.000211	0.00116	CcSEcCtD
Ceftibuten—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000211	0.00116	CcSEcCtD
Ceftibuten—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00021	0.00115	CcSEcCtD
Ceftibuten—Constipation—Gliclazide—type 2 diabetes mellitus	0.00021	0.00115	CcSEcCtD
Ceftibuten—Rash—Glimepiride—type 2 diabetes mellitus	0.000209	0.00115	CcSEcCtD
Ceftibuten—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000209	0.00115	CcSEcCtD
Ceftibuten—Rash—Sitagliptin—type 2 diabetes mellitus	0.000208	0.00114	CcSEcCtD
Ceftibuten—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000208	0.00114	CcSEcCtD
Ceftibuten—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000208	0.00114	CcSEcCtD
Ceftibuten—Headache—Glimepiride—type 2 diabetes mellitus	0.000208	0.00114	CcSEcCtD
Ceftibuten—Headache—Sitagliptin—type 2 diabetes mellitus	0.000207	0.00114	CcSEcCtD
Ceftibuten—Agitation—Losartan—type 2 diabetes mellitus	0.000205	0.00113	CcSEcCtD
Ceftibuten—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000205	0.00112	CcSEcCtD
Ceftibuten—Insomnia—Valsartan—type 2 diabetes mellitus	0.000204	0.00112	CcSEcCtD
Ceftibuten—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000202	0.00111	CcSEcCtD
Ceftibuten—Insomnia—Orlistat—type 2 diabetes mellitus	0.000201	0.00111	CcSEcCtD
Ceftibuten—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000201	0.0011	CcSEcCtD
Ceftibuten—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000201	0.0011	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000201	0.0011	CcSEcCtD
Ceftibuten—Somnolence—Valsartan—type 2 diabetes mellitus	0.0002	0.0011	CcSEcCtD
Ceftibuten—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.0002	0.0011	CcSEcCtD
Ceftibuten—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000198	0.00109	CcSEcCtD
Ceftibuten—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000198	0.00108	CcSEcCtD
Ceftibuten—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000198	0.00108	CcSEcCtD
Ceftibuten—Nausea—Glimepiride—type 2 diabetes mellitus	0.000197	0.00108	CcSEcCtD
Ceftibuten—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000196	0.00108	CcSEcCtD
Ceftibuten—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000196	0.00108	CcSEcCtD
Ceftibuten—Asthenia—Glyburide—type 2 diabetes mellitus	0.000196	0.00108	CcSEcCtD
Ceftibuten—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000196	0.00108	CcSEcCtD
Ceftibuten—Anorexia—Metformin—type 2 diabetes mellitus	0.000196	0.00107	CcSEcCtD
Ceftibuten—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000195	0.00107	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000195	0.00107	CcSEcCtD
Ceftibuten—Fatigue—Valsartan—type 2 diabetes mellitus	0.000194	0.00107	CcSEcCtD
Ceftibuten—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000194	0.00106	CcSEcCtD
Ceftibuten—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000194	0.00106	CcSEcCtD
Ceftibuten—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000194	0.00106	CcSEcCtD
Ceftibuten—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000194	0.00106	CcSEcCtD
Ceftibuten—Pruritus—Glyburide—type 2 diabetes mellitus	0.000193	0.00106	CcSEcCtD
Ceftibuten—Constipation—Valsartan—type 2 diabetes mellitus	0.000193	0.00106	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000192	0.00106	CcSEcCtD
Ceftibuten—Fatigue—Orlistat—type 2 diabetes mellitus	0.000192	0.00105	CcSEcCtD
Ceftibuten—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00019	0.00104	CcSEcCtD
Ceftibuten—Rash—Bromocriptine—type 2 diabetes mellitus	0.000188	0.00103	CcSEcCtD
Ceftibuten—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000188	0.00103	CcSEcCtD
Ceftibuten—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000188	0.00103	CcSEcCtD
Ceftibuten—Headache—Bromocriptine—type 2 diabetes mellitus	0.000187	0.00103	CcSEcCtD
Ceftibuten—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000187	0.00103	CcSEcCtD
Ceftibuten—Dry mouth—Losartan—type 2 diabetes mellitus	0.000186	0.00102	CcSEcCtD
Ceftibuten—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000185	0.00101	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000184	0.00101	CcSEcCtD
Ceftibuten—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000184	0.00101	CcSEcCtD
Ceftibuten—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000183	0.001	CcSEcCtD
Ceftibuten—Somnolence—Metformin—type 2 diabetes mellitus	0.000182	0.001	CcSEcCtD
Ceftibuten—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000182	0.001	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000182	0.001	CcSEcCtD
Ceftibuten—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000181	0.000992	CcSEcCtD
Ceftibuten—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000181	0.000992	CcSEcCtD
Ceftibuten—Urticaria—Valsartan—type 2 diabetes mellitus	0.000179	0.000983	CcSEcCtD
Ceftibuten—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000178	0.000979	CcSEcCtD
Ceftibuten—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000178	0.000978	CcSEcCtD
Ceftibuten—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000178	0.000974	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000177	0.000973	CcSEcCtD
Ceftibuten—Fatigue—Metformin—type 2 diabetes mellitus	0.000177	0.000971	CcSEcCtD
Ceftibuten—Urticaria—Orlistat—type 2 diabetes mellitus	0.000177	0.000971	CcSEcCtD
Ceftibuten—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000176	0.000966	CcSEcCtD
Ceftibuten—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000176	0.000966	CcSEcCtD
Ceftibuten—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000176	0.000966	CcSEcCtD
Ceftibuten—Agitation—Ramipril—type 2 diabetes mellitus	0.000176	0.000966	CcSEcCtD
Ceftibuten—Constipation—Metformin—type 2 diabetes mellitus	0.000176	0.000963	CcSEcCtD
Ceftibuten—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000174	0.000955	CcSEcCtD
Ceftibuten—Anorexia—Losartan—type 2 diabetes mellitus	0.000174	0.000954	CcSEcCtD
Ceftibuten—Vomiting—Glyburide—type 2 diabetes mellitus	0.000174	0.000954	CcSEcCtD
Ceftibuten—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000174	0.000953	CcSEcCtD
Ceftibuten—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000173	0.000948	CcSEcCtD
Ceftibuten—Rash—Glyburide—type 2 diabetes mellitus	0.000172	0.000946	CcSEcCtD
Ceftibuten—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000172	0.000945	CcSEcCtD
Ceftibuten—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000172	0.000945	CcSEcCtD
Ceftibuten—Headache—Glyburide—type 2 diabetes mellitus	0.000171	0.000939	CcSEcCtD
Ceftibuten—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000171	0.000936	CcSEcCtD
Ceftibuten—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000168	0.000924	CcSEcCtD
Ceftibuten—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000168	0.000921	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000168	0.000921	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000167	0.000918	CcSEcCtD
Ceftibuten—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000167	0.000917	CcSEcCtD
Ceftibuten—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000166	0.000912	CcSEcCtD
Ceftibuten—Convulsion—Ramipril—type 2 diabetes mellitus	0.000166	0.000911	CcSEcCtD
Ceftibuten—Constipation—Irbesartan—type 2 diabetes mellitus	0.000166	0.000909	CcSEcCtD
Ceftibuten—Insomnia—Losartan—type 2 diabetes mellitus	0.000165	0.000905	CcSEcCtD
Ceftibuten—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000164	0.000901	CcSEcCtD
Ceftibuten—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000164	0.000898	CcSEcCtD
Ceftibuten—Urticaria—Metformin—type 2 diabetes mellitus	0.000163	0.000895	CcSEcCtD
Ceftibuten—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000163	0.000892	CcSEcCtD
Ceftibuten—Nausea—Glyburide—type 2 diabetes mellitus	0.000162	0.000891	CcSEcCtD
Ceftibuten—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000162	0.000891	CcSEcCtD
Ceftibuten—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000162	0.00089	CcSEcCtD
Ceftibuten—Somnolence—Losartan—type 2 diabetes mellitus	0.000162	0.00089	CcSEcCtD
Ceftibuten—Asthenia—Valsartan—type 2 diabetes mellitus	0.000162	0.000888	CcSEcCtD
Ceftibuten—Dyspepsia—Losartan—type 2 diabetes mellitus	0.00016	0.000881	CcSEcCtD
Ceftibuten—Asthenia—Orlistat—type 2 diabetes mellitus	0.00016	0.000877	CcSEcCtD
Ceftibuten—Pruritus—Valsartan—type 2 diabetes mellitus	0.000159	0.000875	CcSEcCtD
Ceftibuten—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000159	0.000875	CcSEcCtD
Ceftibuten—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000158	0.00087	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000158	0.000869	CcSEcCtD
Ceftibuten—Pruritus—Orlistat—type 2 diabetes mellitus	0.000158	0.000865	CcSEcCtD
Ceftibuten—Fatigue—Losartan—type 2 diabetes mellitus	0.000157	0.000863	CcSEcCtD
Ceftibuten—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000156	0.000858	CcSEcCtD
Ceftibuten—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000156	0.000856	CcSEcCtD
Ceftibuten—Constipation—Losartan—type 2 diabetes mellitus	0.000156	0.000856	CcSEcCtD
Ceftibuten—Rash—Gliclazide—type 2 diabetes mellitus	0.000155	0.000849	CcSEcCtD
Ceftibuten—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000155	0.000848	CcSEcCtD
Ceftibuten—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000154	0.000847	CcSEcCtD
Ceftibuten—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000154	0.000845	CcSEcCtD
Ceftibuten—Headache—Gliclazide—type 2 diabetes mellitus	0.000154	0.000844	CcSEcCtD
Ceftibuten—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000153	0.000841	CcSEcCtD
Ceftibuten—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000153	0.000841	CcSEcCtD
Ceftibuten—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000152	0.000836	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000149	0.000818	CcSEcCtD
Ceftibuten—Dizziness—Valsartan—type 2 diabetes mellitus	0.000149	0.000818	CcSEcCtD
Ceftibuten—Anorexia—Ramipril—type 2 diabetes mellitus	0.000149	0.000818	CcSEcCtD
Ceftibuten—Dizziness—Orlistat—type 2 diabetes mellitus	0.000147	0.000808	CcSEcCtD
Ceftibuten—Asthenia—Metformin—type 2 diabetes mellitus	0.000147	0.000808	CcSEcCtD
Ceftibuten—Nausea—Gliclazide—type 2 diabetes mellitus	0.000146	0.0008	CcSEcCtD
Ceftibuten—Pruritus—Metformin—type 2 diabetes mellitus	0.000145	0.000797	CcSEcCtD
Ceftibuten—Urticaria—Losartan—type 2 diabetes mellitus	0.000145	0.000795	CcSEcCtD
Ceftibuten—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000144	0.000791	CcSEcCtD
Ceftibuten—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000144	0.000791	CcSEcCtD
Ceftibuten—Vomiting—Valsartan—type 2 diabetes mellitus	0.000143	0.000787	CcSEcCtD
Ceftibuten—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000143	0.000783	CcSEcCtD
Ceftibuten—Rash—Valsartan—type 2 diabetes mellitus	0.000142	0.00078	CcSEcCtD
Ceftibuten—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000142	0.000779	CcSEcCtD
Ceftibuten—Vomiting—Orlistat—type 2 diabetes mellitus	0.000142	0.000777	CcSEcCtD
Ceftibuten—Insomnia—Ramipril—type 2 diabetes mellitus	0.000141	0.000776	CcSEcCtD
Ceftibuten—Headache—Valsartan—type 2 diabetes mellitus	0.000141	0.000775	CcSEcCtD
Ceftibuten—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00014	0.000771	CcSEcCtD
Ceftibuten—Rash—Orlistat—type 2 diabetes mellitus	0.00014	0.000771	CcSEcCtD
Ceftibuten—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.00014	0.00077	CcSEcCtD
Ceftibuten—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00014	0.00077	CcSEcCtD
Ceftibuten—Headache—Orlistat—type 2 diabetes mellitus	0.00014	0.000766	CcSEcCtD
Ceftibuten—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000139	0.000765	CcSEcCtD
Ceftibuten—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000139	0.000763	CcSEcCtD
Ceftibuten—Somnolence—Ramipril—type 2 diabetes mellitus	0.000139	0.000763	CcSEcCtD
Ceftibuten—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000138	0.000755	CcSEcCtD
Ceftibuten—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000137	0.000752	CcSEcCtD
Ceftibuten—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000136	0.000746	CcSEcCtD
Ceftibuten—Dizziness—Metformin—type 2 diabetes mellitus	0.000136	0.000745	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000135	0.000741	CcSEcCtD
Ceftibuten—Fatigue—Ramipril—type 2 diabetes mellitus	0.000135	0.00074	CcSEcCtD
Ceftibuten—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000134	0.000737	CcSEcCtD
Ceftibuten—Nausea—Valsartan—type 2 diabetes mellitus	0.000134	0.000735	CcSEcCtD
Ceftibuten—Constipation—Ramipril—type 2 diabetes mellitus	0.000134	0.000734	CcSEcCtD
Ceftibuten—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000133	0.000727	CcSEcCtD
Ceftibuten—Nausea—Orlistat—type 2 diabetes mellitus	0.000132	0.000726	CcSEcCtD
Ceftibuten—Asthenia—Losartan—type 2 diabetes mellitus	0.000131	0.000718	CcSEcCtD
Ceftibuten—Vomiting—Metformin—type 2 diabetes mellitus	0.000131	0.000716	CcSEcCtD
Ceftibuten—Rash—Metformin—type 2 diabetes mellitus	0.000129	0.00071	CcSEcCtD
Ceftibuten—Dermatitis—Metformin—type 2 diabetes mellitus	0.000129	0.00071	CcSEcCtD
Ceftibuten—Pruritus—Losartan—type 2 diabetes mellitus	0.000129	0.000708	CcSEcCtD
Ceftibuten—Headache—Metformin—type 2 diabetes mellitus	0.000129	0.000706	CcSEcCtD
Ceftibuten—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000128	0.000703	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000128	0.000702	CcSEcCtD
Ceftibuten—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000125	0.000685	CcSEcCtD
Ceftibuten—Urticaria—Ramipril—type 2 diabetes mellitus	0.000124	0.000682	CcSEcCtD
Ceftibuten—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000124	0.000678	CcSEcCtD
Ceftibuten—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000124	0.000678	CcSEcCtD
Ceftibuten—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000123	0.000676	CcSEcCtD
Ceftibuten—Rash—Irbesartan—type 2 diabetes mellitus	0.000122	0.00067	CcSEcCtD
Ceftibuten—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000122	0.00067	CcSEcCtD
Ceftibuten—Nausea—Metformin—type 2 diabetes mellitus	0.000122	0.000669	CcSEcCtD
Ceftibuten—Headache—Irbesartan—type 2 diabetes mellitus	0.000121	0.000666	CcSEcCtD
Ceftibuten—Dizziness—Losartan—type 2 diabetes mellitus	0.000121	0.000662	CcSEcCtD
Ceftibuten—Vomiting—Losartan—type 2 diabetes mellitus	0.000116	0.000636	CcSEcCtD
Ceftibuten—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000115	0.000632	CcSEcCtD
Ceftibuten—Nausea—Irbesartan—type 2 diabetes mellitus	0.000115	0.000632	CcSEcCtD
Ceftibuten—Rash—Losartan—type 2 diabetes mellitus	0.000115	0.000631	CcSEcCtD
Ceftibuten—Dermatitis—Losartan—type 2 diabetes mellitus	0.000115	0.00063	CcSEcCtD
Ceftibuten—Headache—Losartan—type 2 diabetes mellitus	0.000114	0.000627	CcSEcCtD
Ceftibuten—Asthenia—Ramipril—type 2 diabetes mellitus	0.000112	0.000616	CcSEcCtD
Ceftibuten—Pruritus—Ramipril—type 2 diabetes mellitus	0.000111	0.000607	CcSEcCtD
Ceftibuten—Nausea—Losartan—type 2 diabetes mellitus	0.000108	0.000594	CcSEcCtD
Ceftibuten—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000107	0.000587	CcSEcCtD
Ceftibuten—Dizziness—Ramipril—type 2 diabetes mellitus	0.000103	0.000567	CcSEcCtD
Ceftibuten—Vomiting—Ramipril—type 2 diabetes mellitus	9.94e-05	0.000546	CcSEcCtD
Ceftibuten—Rash—Ramipril—type 2 diabetes mellitus	9.86e-05	0.000541	CcSEcCtD
Ceftibuten—Dermatitis—Ramipril—type 2 diabetes mellitus	9.85e-05	0.00054	CcSEcCtD
Ceftibuten—Headache—Ramipril—type 2 diabetes mellitus	9.79e-05	0.000537	CcSEcCtD
Ceftibuten—Nausea—Ramipril—type 2 diabetes mellitus	9.29e-05	0.00051	CcSEcCtD
